ERBB2 and breast cancer: In HR-/HER2 + breast cancer, N stage (P = 0.043), histological grade (P = 0.015), P53 status (P = 0.017) and neoadjuvant efficacy (P = 0.040) were determined to be the predictive factors of recurrence and metastasis by univariate analysis.